• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习提高了韩国接受乳腺癌化疗的住院患者发热性中性粒细胞减少症预测的准确性。

Machine learning improves the prediction of febrile neutropenia in Korean inpatients undergoing chemotherapy for breast cancer.

机构信息

Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea.

Institute of New Frontier Research, Hallym University College of Medicine, Chuncheon, Korea.

出版信息

Sci Rep. 2020 Sep 9;10(1):14803. doi: 10.1038/s41598-020-71927-6.

DOI:10.1038/s41598-020-71927-6
PMID:32908182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7481240/
Abstract

Febrile neutropenia (FN) is one of the most concerning complications of chemotherapy, and its prediction remains difficult. This study aimed to reveal the risk factors for and build the prediction models of FN using machine learning algorithms. Medical records of hospitalized patients who underwent chemotherapy after surgery for breast cancer between May 2002 and September 2018 were selectively reviewed for development of models. Demographic, clinical, pathological, and therapeutic data were analyzed to identify risk factors for FN. Using machine learning algorithms, prediction models were developed and evaluated for performance. Of 933 selected inpatients with a mean age of 51.8 ± 10.7 years, FN developed in 409 (43.8%) patients. There was a significant difference in FN incidence according to age, staging, taxane-based regimen, and blood count 5 days after chemotherapy. The area under the curve (AUC) built based on these findings was 0.870 on the basis of logistic regression. The AUC improved by machine learning was 0.908. Machine learning improves the prediction of FN in patients undergoing chemotherapy for breast cancer compared to the conventional statistical model. In these high-risk patients, primary prophylaxis with granulocyte colony-stimulating factor could be considered.

摘要

发热性中性粒细胞减少症(FN)是化疗最令人关注的并发症之一,其预测仍然困难。本研究旨在利用机器学习算法揭示 FN 的危险因素,并建立预测模型。选择性回顾了 2002 年 5 月至 2018 年 9 月间接受乳腺癌手术后化疗的住院患者的病历,以开发模型。分析了人口统计学、临床、病理和治疗数据,以确定 FN 的危险因素。使用机器学习算法开发并评估了预测模型的性能。在 933 名平均年龄为 51.8±10.7 岁的入选患者中,409 名(43.8%)患者发生 FN。FN 的发病率根据年龄、分期、紫杉烷类方案和化疗后 5 天的血细胞计数有显著差异。基于这些发现的逻辑回归构建的曲线下面积(AUC)为 0.870。机器学习的 AUC 提高到 0.908。与传统的统计模型相比,机器学习可提高接受乳腺癌化疗患者 FN 的预测能力。对于这些高危患者,可以考虑使用粒细胞集落刺激因子进行一级预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/07ba6a1c3003/41598_2020_71927_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/9b94afc1e658/41598_2020_71927_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/ee3cd5b575ff/41598_2020_71927_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/07ba6a1c3003/41598_2020_71927_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/9b94afc1e658/41598_2020_71927_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/ee3cd5b575ff/41598_2020_71927_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/7481240/07ba6a1c3003/41598_2020_71927_Fig3_HTML.jpg

相似文献

1
Machine learning improves the prediction of febrile neutropenia in Korean inpatients undergoing chemotherapy for breast cancer.机器学习提高了韩国接受乳腺癌化疗的住院患者发热性中性粒细胞减少症预测的准确性。
Sci Rep. 2020 Sep 9;10(1):14803. doi: 10.1038/s41598-020-71927-6.
2
Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.生物类似药非格司亭与原研粒细胞集落刺激因子在预防乳腺癌患者发热性中性粒细胞减少症中的有效性比较
Eur J Clin Pharmacol. 2018 Mar;74(3):315-321. doi: 10.1007/s00228-017-2365-5. Epub 2017 Nov 19.
3
Pegfilgrastim for the prevention of febrile neutropenia in patients with epithelial ovarian carcinoma--a cost-effectiveness analysis.聚乙二醇化重组人粒细胞刺激因子预防上皮性卵巢癌患者发热性中性粒细胞减少症的成本效益分析
Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1019-24. doi: 10.1111/j.1525-1438.2007.00915.x. Epub 2007 Mar 26.
4
Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The FENCE score.实体瘤患者化疗周期 2-6 期间发热性中性粒细胞减少症的周期特异性风险评分的制定和验证:FENCE 评分。
Int J Cancer. 2020 Jan 15;146(2):321-328. doi: 10.1002/ijc.32249. Epub 2019 Mar 28.
5
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice.中性粒细胞减少症的管理和粒细胞集落刺激因子在接受骨髓抑制化疗的实体瘤患者中的应用——来自临床实践的发现。
Support Care Cancer. 2014 Mar;22(3):667-77. doi: 10.1007/s00520-013-2021-2. Epub 2013 Oct 24.
6
The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis.早期乳腺癌患者使用多西他赛和环磷酰胺方案发生发热性中性粒细胞减少的风险及G-CSF一级预防的必要性:一项荟萃分析
Breast Cancer Res Treat. 2015 Oct;153(3):591-7. doi: 10.1007/s10549-015-3531-z. Epub 2015 Sep 4.
7
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.预防性给予粒细胞集落刺激因子在表柔比星和环磷酰胺化疗治疗日本乳腺癌患者中的应用:一项回顾性研究。
Cancer Chemother Pharmacol. 2019 Nov;84(5):1107-1114. doi: 10.1007/s00280-019-03948-6. Epub 2019 Sep 9.
8
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.仅在第一个和第二个化疗周期中使用初级粒细胞集落刺激因子预防,或在所有化疗周期中使用初级粒细胞集落刺激因子预防,用于有发热性中性粒细胞减少风险的乳腺癌患者。
J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29.
9
Febrile neutropenia in FEC-D regimen for early stage breast cancer: is there a place for G-CSF primary prophylaxis?FEC-D方案治疗早期乳腺癌时的发热性中性粒细胞减少症:粒细胞集落刺激因子一级预防是否可行?
Breast Dis. 2015;35(3):167-71. doi: 10.3233/BD-150411.
10
Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting.在临床试验环境之外的中等收入国家,基于紫杉烷的辅助化疗用于乳腺癌治疗时与治疗相关死亡和发热性中性粒细胞减少的风险。
Asian Pac J Cancer Prev. 2012;13(9):4623-6. doi: 10.7314/apjcp.2012.13.9.4623.

引用本文的文献

1
Clinical prediction models for febrile neutropenia and its outcomes: a systematic review.发热性中性粒细胞减少症及其预后的临床预测模型:一项系统评价
Support Care Cancer. 2025 Jun 4;33(7):537. doi: 10.1007/s00520-025-09562-y.
2
Negative Effect of Intravenous Antibiotics on Survival in Patients with Triple-Negative Breast Cancer.静脉注射抗生素对三阴性乳腺癌患者生存的负面影响。
Cancers (Basel). 2025 Apr 29;17(9):1498. doi: 10.3390/cancers17091498.
3
Factors Affecting Delayed Recovery from Neutropenia in Patients with Pancreatic Cancer Receiving Gemcitabine plus Nab-Paclitaxel.
接受吉西他滨联合白蛋白结合型紫杉醇治疗的胰腺癌患者中性粒细胞减少延迟恢复的影响因素
J Cancer. 2025 Jan 21;16(5):1413-1419. doi: 10.7150/jca.107359. eCollection 2025.
4
Prediction of the Cause of Fundus-Obscuring Vitreous Hemorrhage Using Machine Learning.使用机器学习预测导致眼底模糊的玻璃体积血的病因
Diagnostics (Basel). 2025 Feb 4;15(3):371. doi: 10.3390/diagnostics15030371.
5
Knowledge, attitude and practice towards chemotherapy-related neutropenia and febrile neutropenia among breast cancer patients.乳腺癌患者对化疗相关中性粒细胞减少症和发热性中性粒细胞减少症的知识、态度和实践。
BMJ Open. 2024 Oct 29;14(10):e089738. doi: 10.1136/bmjopen-2024-089738.
6
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology.人工智能在预测转移性结直肠癌化疗所致毒性中的应用:一种用于个性化肿瘤学的数据驱动方法。
Diagnostics (Basel). 2024 Sep 19;14(18):2074. doi: 10.3390/diagnostics14182074.
7
Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer.化疗期间血液学参数对癌症患者发热性中性粒细胞减少症的预测价值。
Front Oncol. 2024 Aug 19;14:1380195. doi: 10.3389/fonc.2024.1380195. eCollection 2024.
8
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models.预测非肌层浸润性膀胱癌患者的复发和进展:风险分层模型性能的系统评价
Bladder Cancer. 2022 Dec 14;8(4):339-357. doi: 10.3233/BLC-220055. eCollection 2022.
9
Prediction of Multiple Clinical Complications in Cancer Patients to Ensure Hospital Preparedness and Improved Cancer Care.预测癌症患者的多种临床并发症,以确保医院做好准备并改善癌症护理。
Int J Environ Res Public Health. 2022 Dec 28;20(1):526. doi: 10.3390/ijerph20010526.
10
COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim.接受TAC化疗并预防性使用培非格司亭的乳腺癌患者的COVID-19预防指南及发热性中性粒细胞减少症的发生率
J Clin Med. 2022 Nov 29;11(23):7053. doi: 10.3390/jcm11237053.